MarketBeat Instant News Alerts 2 hours agoAcuity (NYSE:AYI) Issues Earnings Results, Beats Estimates By $0.20 EPSMarketBeatAcuity (NYSE:AYI - Get Free Report) issued its quarterly earnings results on Thursday. The electronics maker reported $5.77 earnings per share for the quarter, topping the consensus estimate of $5.57 by $0.20. Acuity had a return on equity of 20.26% and a net margin of 10.25%.The firm had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.24 billion. During the same period in the prior year, the business posted $5.20 earnings per share. The company's revenue for the quarter was up 2.9% on a year-over-year basis. NYSE:AYIRead Acuity (NYSE:AYI) Issues Earnings Results, Beats Estimates By $0.20 EPS2 hours agoIntegra LifeSciences (NASDAQ:IART) Releases Q3 2026 Earnings GuidanceMarketBeatIntegra LifeSciences (NASDAQ:IART) updated its third quarter 2026 earnings guidance. The company provided EPS guidance of 0.550-0.590 for the period, compared to the consensus estimate of 0.560. NASDAQ:IARTRead Integra LifeSciences (NASDAQ:IART) Releases Q3 2026 Earnings Guidance2 hours agoIntegra LifeSciences (NASDAQ:IART) Releases FY 2026 Earnings GuidanceMarketBeatIntegra LifeSciences (NASDAQ:IART) updated its FY 2026 earnings guidance. The company provided EPS guidance of 2.300-2.400 for the period, compared to the consensus estimate of 2.460. NASDAQ:IARTRead Integra LifeSciences (NASDAQ:IART) Releases FY 2026 Earnings Guidance2 hours agoPenguin Solutions (NASDAQ:PENG) Stock Rating Reaffirmed as "Buy" by Rosenblatt SecuritiesMarketBeatRosenblatt Securities reaffirmed a "buy" rating and set a $80.00 price target on shares of Penguin Solutions in a report on Friday.NASDAQ:PENGRead Penguin Solutions (NASDAQ:PENG) Stock Rating Reaffirmed as "Buy" by Rosenblatt Securities2 hours agoMiami International (NYSE:MIAX) Given Buy Rating at Rosenblatt SecuritiesMarketBeatRosenblatt Securities reiterated a "buy" rating and issued a $62.00 target price on shares of Miami International in a research note on Friday.NYSE:MIAXRead Miami International (NYSE:MIAX) Given Buy Rating at Rosenblatt Securities2 hours agoRosenblatt Securities Issues Positive Forecast for Synaptics (NASDAQ:SYNA) Stock PriceMarketBeatRosenblatt Securities increased their price target on Synaptics from $115.00 to $123.00 and gave the stock a "neutral" rating in a research note on Friday.NASDAQ:SYNARead Rosenblatt Securities Issues Positive Forecast for Synaptics (NASDAQ:SYNA) Stock Price Trending News1Rivian Eyes Late-Year Autonomy Rollout as R2 Production Ramp Takes Center Stage2Aurora Innovation (NASDAQ:AUR) Shares Down 6.7% - Here's Why3Intel (NASDAQ:INTC) Shares Down 5.7% - Here's Why4QuantumScape (NYSE:QS) Shares Down 6.4% - Here's What Happened5USA Rare Earth (NASDAQ:USAR) Stock Price Down 5% - Here's What Happened6Rocket Lab (NASDAQ:RKLB) Stock Jumps 6.2% - Here's Why7IREN (NASDAQ:IREN) Stock Falls 1.2% on Analyst Downgrade8Oracle (NYSE:ORCL) Stock Rating Reaffirmed as Buy by Sanford C. Bernstein All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoNIKE's (NKE) "Hold" Rating Reiterated at Needham & Company LLCMarketBeatNYSE:NKERead NIKE's (NKE) "Hold" Rating Reiterated at Needham & Company LLC2 hours agoRobert W. Baird Has Lowered Expectations for Fair Isaac (NYSE:FICO) Stock PriceMarketBeatNYSE:FICORead Robert W. Baird Has Lowered Expectations for Fair Isaac (NYSE:FICO) Stock Price2 hours agoNautilus Biotechnology, Inc. (NASDAQ:NAUT) Stock Has Average Price Target of $3.83MarketBeatNASDAQ:NAUTRead Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Stock Has Average Price Target of $3.832 hours agoCPB Inc. (NYSE:CPF) Stock Now Rated "Moderate Buy" by Wall Street AnalystsMarketBeatNYSE:CPFRead CPB Inc. (NYSE:CPF) Stock Now Rated "Moderate Buy" by Wall Street Analysts2 hours agoPimco Corporate & Income Opportunity Fund (NYSE:PTY) Shares Will Pay Monthly Dividend of $0.12MarketBeatNYSE:PTYRead Pimco Corporate & Income Opportunity Fund (NYSE:PTY) Shares Will Pay Monthly Dividend of $0.122 hours agoBank OZK (NASDAQ:OZK) Increases Dividend to $0.49 Per ShareMarketBeatNASDAQ:OZKRead Bank OZK (NASDAQ:OZK) Increases Dividend to $0.49 Per Share2 hours agoNIKE (NYSE:NKE) Given New $50.00 Price Target at BTIG ResearchMarketBeatNYSE:NKERead NIKE (NYSE:NKE) Given New $50.00 Price Target at BTIG Research2 hours agoonsemi (NASDAQ:ON) Stock Keeps "Buy" Rating at Needham & Company LLCMarketBeatNASDAQ:ONRead onsemi (NASDAQ:ON) Stock Keeps "Buy" Rating at Needham & Company LLC2 hours agoAbbott Laboratories (NYSE:ABT) Upgraded to "Buy" at Rothschild & Co RedburnMarketBeatNYSE:ABTRead Abbott Laboratories (NYSE:ABT) Upgraded to "Buy" at Rothschild & Co Redburn2 hours agoBTIG Research Reaffirms "Buy" Rating for ServiceTitan (NASDAQ:TTAN)MarketBeatNASDAQ:TTANRead BTIG Research Reaffirms "Buy" Rating for ServiceTitan (NASDAQ:TTAN)2 hours agoLSI Industries' (LYTS) "Buy" Rating Reaffirmed at HC WainwrightMarketBeatNASDAQ:LYTSRead LSI Industries' (LYTS) "Buy" Rating Reaffirmed at HC Wainwright2 hours agoAccenture (NYSE:ACN) Price Target Raised to $195.00MarketBeatNYSE:ACNRead Accenture (NYSE:ACN) Price Target Raised to $195.002 hours agoConnect Biopharma (NASDAQ:CNTB) Given Buy Rating at HC WainwrightMarketBeatNASDAQ:CNTBRead Connect Biopharma (NASDAQ:CNTB) Given Buy Rating at HC Wainwright2 hours agoMizuho Upgrades Anadarko Petroleum (NASDAQ:APC) to OutperformMarketBeatNASDAQ:APCRead Mizuho Upgrades Anadarko Petroleum (NASDAQ:APC) to Outperform2 hours agoCullinan Therapeutics (NASDAQ:CGEM) Earns Buy Rating from HC WainwrightMarketBeatNASDAQ:CGEMRead Cullinan Therapeutics (NASDAQ:CGEM) Earns Buy Rating from HC Wainwright2 hours agoShattuck Labs (NASDAQ:STTK) Stock Price Expected to Rise, Needham & Company LLC Analyst SaysMarketBeatNASDAQ:STTKRead Shattuck Labs (NASDAQ:STTK) Stock Price Expected to Rise, Needham & Company LLC Analyst Says2 hours agoHC Wainwright Cuts Liquidia (NASDAQ:LQDA) Price Target to $58.00MarketBeatNASDAQ:LQDARead HC Wainwright Cuts Liquidia (NASDAQ:LQDA) Price Target to $58.002 hours agoBetter Home & Finance (NASDAQ:BETR) Raised to Overweight at Cantor FitzgeraldMarketBeatNASDAQ:BETRRead Better Home & Finance (NASDAQ:BETR) Raised to Overweight at Cantor Fitzgerald2 hours agoArtiva Biotherapeutics (NASDAQ:ARTV) Given "Overweight" Rating at Cantor FitzgeraldMarketBeatNASDAQ:ARTVRead Artiva Biotherapeutics (NASDAQ:ARTV) Given "Overweight" Rating at Cantor Fitzgerald2 hours agoBank of America Forecasts Strong Price Appreciation for XPO (NYSE:XPO) StockMarketBeatNYSE:XPORead Bank of America Forecasts Strong Price Appreciation for XPO (NYSE:XPO) Stock2 hours agoMarathon Petroleum (NYSE:MPC) Price Target Raised to $426.00MarketBeatNYSE:MPCRead Marathon Petroleum (NYSE:MPC) Price Target Raised to $426.002 hours agoValero Energy (NYSE:VLO) Stock Price Expected to Rise, Bank of America Analyst SaysMarketBeatNYSE:VLORead Valero Energy (NYSE:VLO) Stock Price Expected to Rise, Bank of America Analyst Says2 hours agoCantor Fitzgerald Reaffirms "Overweight" Rating for MongoDB (NASDAQ:MDB)MarketBeatNASDAQ:MDBRead Cantor Fitzgerald Reaffirms "Overweight" Rating for MongoDB (NASDAQ:MDB)2 hours agoHC Wainwright Cuts Foghorn Therapeutics (NASDAQ:FHTX) Price Target to $5.00MarketBeatNASDAQ:FHTXRead HC Wainwright Cuts Foghorn Therapeutics (NASDAQ:FHTX) Price Target to $5.00 Featured Articles and OffersDeutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?By Sam Quirke | September 30, 2026This AI fund posted a 34 percent annualized payout last monthFrom Investors Alley (Ad)Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?By Chris Markoch | September 28, 2026Data Centers Got the AI Hype—But Office REITs May Get the Rent HikesBy Chris Markoch | September 27, 2026Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-OutBy Thomas Hughes | September 29, 2026A letter from Shannon StansberryFrom Porter & Company (Ad)CarMax Just Gave Investors a Better Reason to Believe in the TurnaroundBy Thomas Hughes | September 29, 2026Everyone in AI Is Quietly Copying Palantir's PlaybookBy Chris Markoch | October 1, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 187 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
